CABI

Cabbacis Inc. focuses on its proprietary iBlend reduced-nicotine cigarettes and vaporizer pods in development and to secure Food and Drug Administration (FDA) authorization to sell its products in the United States through the Premarket Tobacco Product Application (PMTA) process. The Company, through its wholly owned subsidiary Cabbacis LLC, operates as a federally licensed, tobacco product manufacturer and plant biotechnology company developing and commercializing consumer acceptable Modified Risk Tobacco Products (MRTPs). It has not commercialized its products which it is developing under the iBlend brand name, and its primary focus is the development of cigarettes with blends of reduced-nicotine tobacco containing about 95 percent less nicotine than that of United States brands and very-low THC cannabis, (commonly known as hemp), which is not intoxicating since it contains less than 0.3 percent THC. The Company is also developing pods for oral electronic vaporizers.